维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Holven KB"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects显示文摘	Holven KB Aukrust P Retterstol K	2008	Journal of nutrition2008，138，11：	1
2	Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects显示文摘	Holven KB Haugstad TS Holm T	2003	Br J Nutr2003，89，3：	1
3	Folic-acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects显示文摘	Holven KB Haugstad TS Holm T	2003	Br J Nutr2003，89，3：	1
4	Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects 显示文摘	Holven KB Holm T Aukrust P	2001	Am J Med2001，110，7：	1
5	Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects显示文摘	Aukrust P Holm T	2002	Arterioscler Thromb Vasc Biol2002，22，4：	1
6	Increased levels of C- reactive protein and inter leukin - 6 in hyperhomocysteinemic subjects显示文摘	Holven KB Aukrust P	2008	Clin Lab In- vest2008，66，1：	1
7	Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells显示文摘	Holven KB Scholz H Halvorsen B	2003	J Nutr2003，133，11：	1
8	Increased level of C reac tire protein a-nd interleukin-6in hyper homocysteinemic subjects 显示文摘	Holven KB Hong KH Park J H	2006	Stand Lab Invest2006，66，1：	1
9	显示文摘	Holven KB Haugstad TS Holm T	2003	Br J Nutr2003，89，：	1
10	Folic acid treatment re- duces ehemokine release from peripheral bloodmononuclear cell in hyperhomocysteinemic subjects 显示文摘	Holven KB Aukrust P Holm T	2002	Atheroscler Thromb Vasc Biol2002，22，：	1
11	Increased levels of C-reactive proteins and interleukin-6 in hyperhomocys- teinemic subjects 显示文摘	Holven KB Aukrust P Retterstol K	2006	Scand J Clin Lab Invest2006，66，：	1
12	Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase- 9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects显示文摘	Holven KB Halvorsen B Bjerkeli V	2006	Stroke2006，37，：	1
13	Increased level of Creactive protein and interleukin-6 in hyperhomocysteinemic subjects显示文摘	Holven KB Aukrust P Retterstol K	2006	Scand J Clin Lab Invest2006，66，1：	1
14	Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects显示文摘	Holven KB Haugstad TS Holm T	2003	Br J Nutr2003，89，：	1
15	Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects显示文摘	Holven KB Haugstad TS Holm T	2003	Br J Nutr2003，89，：	1
16	Folic acid treament reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects显示文摘	Holven KB Haugstad TS Holm T	2003	Br J Nutr2003，89，3：	1
17	Hyperho-mocysteinemic subjects have enhanced expression oflectin-like oxidized LDL receptor-1in mononuclear cells显示文摘	Holven KB Scholz H Halvorsen B	2003	J Nutr2003，133，：	1
18	Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects 显示文摘	Holven KB Halvorsen B Bjerkeli V	2006	Stroke2006，37，7：	1
19	Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects显示文摘	Holven KB Halvorsen B Sehulz H	2003	Eur J Clin Invest2003，33，7：	1
20	Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects显示文摘	Holven KB Aukrust P Retterstol K	2006	Scand J Cin Lab Invest2006，669，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示